Cargando…

Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs

Detalles Bibliográficos
Autores principales:	Malapelle, Umberto, Pallante, Pierlorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439169/ https://www.ncbi.nlm.nih.gov/pubmed/28589123 http://dx.doi.org/10.3389/fmed.2017.00063

Ejemplares similares

Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib
por: Corrales, Luis, et al.
Publicado: (2017)

Editorial: Molecular pathology and computational image analyses in gynecologic malignancies
por: Malapelle, Umberto, et al.
Publicado: (2022)

Liquid Biopsy Is a Promising Tool for Genetic Testing in Idiopathic Pulmonary Fibrosis
por: Pallante, Pierlorenzo, et al.
Publicado: (2021)

High Mobility Group A Proteins as Tumor Markers
por: Pallante, Pierlorenzo, et al.
Publicado: (2015)

The Promise of Digital Biopsy for the Prediction of Tumor Molecular Features and Clinical Outcomes Associated With Immunotherapy
por: Banna, Giuseppe Luigi, et al.
Publicado: (2019)

Editorial: Molecular predictive pathology in gynecologic malignancies
por: Malapelle, Umberto, et al.
Publicado: (2023)

Second-line avelumab in platinum-treated non-small cell lung cancer patients: comment on the JAVELIN Lung 200 clinical trial
por: Rocco, Danilo, et al.
Publicado: (2019)

Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer
por: Lazzari, Chiara, et al.
Publicado: (2017)

Editorial: Small cell lung cancer: New drugs and strategies
por: Cortinovis, Diego L., et al.
Publicado: (2023)

Editorial: Long non-coding RNAs in lung cancer
por: Malapelle, Umberto, et al.
Publicado: (2022)

Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib
por: Zugazagoitia, Jon, et al.
Publicado: (2017)

Editorial: Cancer diagnostics in solid tumors-from pathology to precision oncology
por: Malapelle, Umberto, et al.
Publicado: (2023)

Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer
por: Pisapia, Pasquale, et al.
Publicado: (2021)

The control of tumor progression by circular RNAs: novel prognostic and therapeutic insights resulting from the analysis of the circAGO2/human antigen R complex
por: Pellecchia, Simona, et al.
Publicado: (2019)

Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies
por: Sandoval-Rodriguez, Ana, et al.
Publicado: (2022)

Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers
por: Fusco, Nicola, et al.
Publicado: (2023)

BRCA1/2 NGS Somatic Testing in Clinical Practice: A Short Report
por: Pepe, Francesco, et al.
Publicado: (2021)

Long non-coding RNAs regulating multiple proliferative pathways in cancer cell
por: De Martino, Marco, et al.
Publicado: (2021)

Targeted therapy and non-small cell lung cancer: a new era!
por: Malapelle, Umberto, et al.
Publicado: (2019)

Editorial: Computational Pathology
por: Bozorgtabar, Behzad, et al.
Publicado: (2020)

Editorial: Molecular aspects of compulsive drug use
por: Lasek, Amy W., et al.
Publicado: (2023)

Biomarkers predictive value in early stage non-small cell lung cancer
por: Malapelle, Umberto, et al.
Publicado: (2020)

Editorial: Molecular Characterization of Thyroid Lesions in the Era of “Next-Generation” Techniques
por: Bellevicine, Claudio, et al.
Publicado: (2022)

Editorial: Molecular Pathology of HTLV-1
por: Bertazzoni, Umberto, et al.
Publicado: (2018)

Editorial: Renal Hypertension at the Crossroads: Theoretical, Experimental and Clinical Aspects
por: Gollasch, Maik, et al.
Publicado: (2020)

Small Cell Lung Cancer: State of the Art of the Molecular and Genetic Landscape and Novel Perspective
por: Denninghoff, Valeria, et al.
Publicado: (2021)

Editorial: Advances in AI methods for computational pathology
por: Qi, Xin, et al.
Publicado: (2022)

Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas
por: De Martino, Marco, et al.
Publicado: (2022)

Editorial: New Trends in Early-Stage Lung Cancer Presenting as Ground-Glass Opacities: Clinical, Pathological and Molecular Aspects
por: Chen, Kezhong, et al.
Publicado: (2021)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Editorial: Women's Lung
por: Domagala-Kulawik, Joanna, et al.
Publicado: (2021)

Editorial: Molecular Aspects of Mucopolysaccharidoses
por: Węgrzyn, Grzegorz, et al.
Publicado: (2022)

First and Second Line Chemotherapeutic Regimens for Non-Small Cell Lung Carcinomas - The Efficacy of Platinum, Non-Platinum and Combination Therapy: A Literature Review
por: Michael, Anita, et al.
Publicado: (2020)

Editorial: Advances in systemic lupus erythematosus: The promises and pitfalls of personalized medicine and patient stratification
por: Marasco, Emiliano, et al.
Publicado: (2022)

CBX7 Modulates the Expression of Genes Critical for Cancer Progression
por: Pallante, Pierlorenzo, et al.
Publicado: (2014)

Editorial: Cholesterol and cancer drug resistance: Molecular, signaling, and therapeutic aspects
por: Kaur, Mandeep, et al.
Publicado: (2022)

Natural Products as Promising Drug Candidates for the Treatment of Alzheimer’s Disease: Molecular Mechanism Aspect
por: Ansari, Niloufar, et al.
Publicado: (2013)

Editorial: Molecular Mechanisms of Proteinuria
por: Merscher, Sandra
Publicado: (2018)

Editorial: Advances in Molecular Cytopathology
por: Vigliar, Elena, et al.
Publicado: (2022)

Editorial: Pathological livers in the surgery of hepatic resections and liver transplantation
por: Peralta, Carmen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9vlr3db07vphq9fqc7rop6drnq